Bio Protocol vs zkPass — how do they compare? Bio Protocol trades at Rp434.7 (market cap Rp982,11M, Rp157,98M 24h volume), while zkPass trades at Rp711.2 (market cap Rp204,86M, Rp122,66M 24h volume). The key difference: Bio Protocol is far larger — about 4.8× zkPass's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 288,3M / 1B ZKP (29%) for zkPass. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and zkPass for 8 Days on average.
| BIO | ZKP | |
|---|---|---|
Market Cap | Rp982,11M | Rp204,86M |
Volume (24h) | Rp157,98M | Rp122,66M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 288,3M / 1B ZKP (29%) |
Typical Hold Time | 18 Days | 8 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
ZKP is currently trading at Rp736.7 with a bearish technical outlook, showing strong selling pressure across moving averages and oscillators. The token trades near its pivot point of Rp743, with immediate support at Rp727 and resistance at Rp757. With only 29% of the 1 million max supply in circulation and an average hold time of 8 days, the asset shows limited distribution but high turnover.
Overall outlook remains cautious due to bearish technical signals and limited fundamental developments. Key opportunities include potential bounce from support levels, while risks involve low liquidity (Rp212.79M market cap) and the absence of recent protocol updates or ecosystem growth catalysts.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →zkPass is a zkTLS-based oracle network designed to enable verifiable proofs from private Web data. It allows applications to securely verify facts from HTTPS sources without exposing personal information or requiring changes to existing systems.
Read more on ZKP →